Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine
Open accessAbstract
Cystic fibrosis (CF) is an inherited disorder where individual disease aetiology and response to therapeutic intervention is impacted by CF transmembrane regulator (CFTR) mutations and other genetic modifiers. CFTR regulates multiple mechanisms in diverse range of epithelial tissues. In this Review, we consolidate the latest updates in the development of primary epithelial cellular model systems relevant for CF. We discuss conventional two-dimensional (2-D) airway epithelial cell cultures, the backbone of in vitro cellular models to date, as well as improved expansion protocols to overcome finite supply of the cellular source. We highlight range of strategies for establishment of the three dimensional (3-D) airway and intestinal organoid models and evaluate the limitations and potential improvements in each system, focusing on their application in CF. The in vitro CFTR functional assays in patient-derived organoids allow for preclinical pharmacotherapy screening to identify responsive patients. It is likely that organoids will be an invaluable preclinical tool to unravel disease mechanisms, design novel treatments and enable clinicians to provide personalized management for patients with CF.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Human primary airway epithelial cells are a physiologically relevant 2-D model for CF disease modeling and preclinical testing of CF therapies.
“Human primary airway epithelial cells are a physiologically relevant 2-D model for CF disease modeling and preclinical testing of CF therapies43,44.”
From Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing (2019) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204 · see citing works
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Héry-Arnaud, G., Berre, R. L., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992 · see citing works
Ratjen, A. K. W. F. A. (2006) · Cited by 4,406 · see citing works
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,667 · see citing works
A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105185 · Cited by 2,195 · see citing works
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del <i>CFTR</i>
Wainwright, C. E., Elborn, J. S., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J. C., De Boeck, K., Flume, P. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1409547 · Cited by 1,622 · see citing works
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Goor, F. V., Hadidaꝉ, S., Grootenhuis, P. D. J., Burton, B., Cao, D., Neuberger, T., Turnbull, A., Singh, A. K., Joubran, J., Hazlewood, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904709106 · Cited by 1,225 · see citing works
A revised airway epithelial hierarchy includes CFTR-expressing ionocytes
Montoro, D. T., Haber, A. L., Biton, M., Vinarsky, V., Lin, B., Birket, S. E., Yuan, F., Chen, S., Leung, H. M., Villoria, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0393-7 · Cited by 1,206 · see citing works
Matsui, H., Grubb, B. R., Tarran, R., Randell, S. H., Gatzy, J. T., Davis, C. W., & Boucher, R. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81724-9 · Cited by 1,168 · see citing works
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105787108 · Cited by 1,088 · see citing works
Long‐term expanding human airway organoids for disease modeling
Sachs, N., Papaspyropoulos, A., Zomer‐van Ommen, D. D., Heo, I., Böttinger, L., Klay, D., Weeber, F., Huelsz‐Prince, G., Iakobachvili, N., Amatngalim, G. D., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100300 · Cited by 1,082 · see citing works
A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte
Plasschaert, L. W., Žilionis, R., Choo-Wing, R., Savova, V., Knehr, J., Roma, G., Klein, A. M., & Jaffe, A. B. (2018) · Nature · doi:10.1038/s41586-018-0394-6 · Cited by 1,047 · see citing works
Self-citationA functional CFTR assay using primary cystic fibrosis intestinal organoids
Dekkers, J. F., Wiegerinck, C. L., de Jonge, H. R., Bronsveld, I., Janssens, H. M., de Winter-de Groot, K. M., Brandsma, A. M., de Jong, N. W. M., Bijvelds, M. J. C., Scholte, B. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3201 · Cited by 999 · see citing works
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice
Mall, M. A., Grubb, B. R., Harkema, J. R., O’Neal, W. K., & Boucher, R. C. (2004) · Nature Medicine · doi:10.1038/nm1028 · Cited by 911 · see citing works
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation
Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M., Dunitz, J., Durie, P. R., Sagel, S. D., Hornick, D. B., Konstan, M. W., Donaldson, S. H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909825 · Cited by 803 · see citing works
Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Taylor-Cousar, J. L., Munck, A., McKone, E. F., van der Ent, C. K., Moeller, A., Simard, C., Wang, L. T., Ingenito, E. P., McKee, C., Lu, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709846 · Cited by 794 · see citing works
Isolation and in vitro expansion of human colonic stem cells
Jung, P., Sato, T., Merlos-Suárez, A., Barriga, F. M., Iglesias, M., Rossell, D., Auer, H., Gallardo, M., Blasco, M. A., Sancho, E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2470 · Cited by 709 · see citing works
CFTR Function and Prospects for Therapy
Riordan, J. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142532 · Cited by 610 · see citing works
Ratjen, F. A., Bell, S. C., Rowe, S. M., Goss, C. H., Quittner, A. L., & Bush, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.10 · Cited by 553 · see citing works
Dekkers, J. F., Berkers, G., Kruisselbrink, E., Vonk, A., de Jonge, H. R., Janssens, H. M., Bronsveld, I., van de Graaf, E. A., Nieuwenhuis, E. E. S., Houwen, R. H. J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8278 · Cited by 548 · see citing works
Pedemonte, N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24898 · Cited by 542 · see citing works
Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis
Rowe, S. M., Daines, C., Ringshausen, F. C., Kerem, E., Wilson, J., Tullis, E., Nair, N., Simard, C., Han, L., Ingenito, E. P., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709847 · Cited by 522 · see citing works
Goor, F. V., Straley, K. S., Cao, D., González, J. E., Hadidaꝉ, S., Hazlewood, A., Joubran, J., Knapp, T., Makings, L. R., Miller, M. A., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00169.2005 · Cited by 515 · see citing works
Clancy, J. P., Rowe, S. M., Accurso, F. J., Aitken, M. L., Amin, R. S., Ashlock, M. A., Ballmann, M., Boyle, M., Bronsveld, I., Campbell, P. W., et al. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200393 · Cited by 514 · see citing works
Davies, J. C., Wainwright, C. E., Canny, G. J., Chilvers, M. A., Howenstine, M. S., Munck, À., Mainz, J. G., Rodriguez, S., Li, H., Yen, K., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201301-0153oc · Cited by 506 · see citing works
Boyle, M., Bell, S. C., Konstan, M. W., McColley, S. A., Rowe, S. M., Rietschel, E., Huang, X., Waltz, D. A., Patel, N. R., & Rodman, D. M. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70132-8 · Cited by 451 · see citing works
Lung organoids: current uses and future promise
Barkauskas, C. E., Chung, M.-I., Fioret, B. A., Gao, X., Katsura, H., & Hogan, B. L. M. (2017) · Development · doi:10.1242/dev.140103 · Cited by 447 · see citing works
Cystic fibrosis: terminology and diagnostic algorithms
Boeck, K. D. (2005) · Thorax · doi:10.1136/thx.2005.043539 · Cited by 387 · see citing works
Dual SMAD Signaling Inhibition Enables Long-Term Expansion of Diverse Epithelial Basal Cells
Mou, H., Vinarsky, V., Tata, P. R., Brazauskas, K., Choi, S. H., Crooke, A. K., Zhang, B., Solomon, G. M., Turner, B., Bihler, H. J., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.05.012 · Cited by 379 · see citing works
Differentiated human airway organoids to assess infectivity of emerging influenza virus
Zhou, J., Li, C., Sachs, N., Chiu, M. C., Wong, B. H., Chu, H., Poon, V. K., Wang, D., Zhao, X., Wen, L., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806308115 · Cited by 316 · see citing works
The genesis of cystic fibrosis lung disease
Wine, J. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6222 · Cited by 275 · see citing works
Notch2 Is Required for Inflammatory Cytokine-Driven Goblet Cell Metaplasia in the Lung
Danahay, H. L., Pessotti, A. D., Coote, J., Montgomery, B. E., Xia, D., Wilson, A. C., Yang, H., Wang, Z., Bevan, L., Thomas, C., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.12.017 · Cited by 252 · see citing works
Self-citationLoss of CFTR Chloride Channels Alters Salt Absorption by Cystic Fibrosis Airway Epithelia In Vitro
Zabner, J., Smith, J. J., Karp, P. H., Widdicombe, J. H., & Welsh, M. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80284-1 · Cited by 251 · see citing works
Keogh, R. H., Szczesniak, R. D., Taylor-Robinson, D. C., & Bilton, D. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.11.019 · Cited by 222 · see citing works
Human airway organoid engineering as a step toward lung regeneration and disease modeling
Tan, Q., Choi, K. M., Sicard, D., & Tschumperlin, D. J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.046 · Cited by 191 · see citing works
Donaldson, S. H., Pilewski, J. M., Griese, M., Cooke, J., Viswanathan, L., Tullis, E. D., Davies, J. C., Lekstrom-Himes, J. A., & Wang, L. T. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201704-0717oc · Cited by 186 · see citing works
Classification of CFTR mutation classes
Marson, F. A. L., Bertuzzo, C. S., & Ribeiro, J. D. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30188-6 · Cited by 183 · see citing works
Human primary bronchial lung cell constructs: The new respiratory models
BéruBé, K., Prytherch, Z. C., Job, C., & Hughes, T. (2010) · Toxicology · doi:10.1016/j.tox.2010.04.004 · Cited by 158 · see citing works
Hirtz, S., Gonska, T. Y., Seydewitz, H. H., Thomas, J., Greiner, P., Kuehr, J., Brandis, M., Eichler, I., Rocha, H., Lopes, A., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.006 · Cited by 152 · see citing works
Pharmacological Rescue of Conditionally Reprogrammed Cystic Fibrosis Bronchial Epithelial Cells
Gentzsch, M., Boyles, S. E., Cheluvaraju, C., Chaudhry, I. G., Quinney, N. L., Cho, C., Dang, H., Liu, X., Schlegel, R., & Randell, S. H. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0276ma · Cited by 148 · see citing works
Derichs, N., Sanz, J., von Känel, T., Stolpe, C., Zapf, A., Tümmler, B., Gallati, S., & Ballmann, M. (2010) · Thorax · doi:10.1136/thx.2009.125088 · Cited by 145 · see citing works
Ex vivo culture of the intestinal epithelium: strategies and applications
Leushacke, M., & Barker, N. (2014) · Gut · doi:10.1136/gutjnl-2014-307204 · Cited by 113 · see citing works
Airway Progenitor Clone Formation Is Enhanced by Y-27632–Dependent Changes in the Transcriptome
Reynolds, S. D., Rios, C. L., Wesolowska‐Andersen, A., Zhuang, Y., Pinter, M., Happoldt, C., Hill, C. L., Lallier, S. W., Cosgrove, G. P., Solomon, G. M., et al. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0274ma · Cited by 106 · see citing works
Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies
Brewington, J. J., Filbrandt, E. T., LaRosa, F. J., Moncivaiz, J. D., Ostmann, A. J., Strecker, L. M., & Clancy, J. P. (2018) · JCI Insight · doi:10.1172/jci.insight.99385 · Cited by 106 · see citing works
Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences
Lavelle, G., White, M. M., Browne, N., McElvaney, N. G., & Reeves, E. P. (2016) · BioMed Research International · doi:10.1155/2016/5258727 · Cited by 104 · see citing works
de Jonge, H. R., Ballmann, M., Veeze, H. J., Bronsveld, I., Stanke, F., Tümmler, B., & Sinaasappel, M. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.05.034 · Cited by 97 · see citing works
Martinovich, K. M., Iosifidis, T., Buckley, A. G., Looi, K., Ling, K.-M., Sutanto, E. N., Kicic-Starcevich, E., Garratt, L. W., Shaw, N. C., Montgomery, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17952-4 · Cited by 96 · see citing works
Self-citationHild, M., & Jaffe, A. B. (2016) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.1 · Cited by 95 · see citing works
Self-citationAwatade, N. T., Uliyakina, I., Farinha, C. M., Clarke, L. A., Mendes, K., Solé, A., Pastor, J., Ramos, M. M. P., & Amaral, M. D. (2014) · EBioMedicine · doi:10.1016/j.ebiom.2014.12.005 · Cited by 75 · see citing works
Self-citationClarke, L. A., Sousa, L., Barreto, C., & Amaral, M. D. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-38 · Cited by 73 · see citing works
Cystic fibrosis: Toward personalized therapies
Ikpa, P. T., Bijvelds, M. J. C., & de Jonge, H. R. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.02.008 · Cited by 72 · see citing works
Sousa, M., Servidoni, M. F., Vinagre, A. M., Ramalho, A. S., Bonadia, L. C., Felício, V., Ribeiro, M. Â. G. D. O., Uliyakina, I., Marson, F. A. L., Kmit, A. H. P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047708 · Cited by 67 · see citing works
Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids
Dekkers, J. F., Gondra, R. A. G., Kruisselbrink, E., Vonk, A. M., Janssens, H. M., Groot, K. M. D. W., van der Ent, C. K., & Beekman, J. M. (2016) · European Respiratory Journal · doi:10.1183/13993003.01192-2015 · Cited by 66 · see citing works
Peters‐Hall, J. R., Coquelin, M. L., Torres, M. J., LaRanger, R., Alabi, B. R., Sho, S., Calva-Moreno, J. F., Thomas, P., & Shay, J. W. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00355.2017 · Cited by 64 · see citing works
Clancy, J. P., Szczesniak, R. D., Ashlock, M. A., Ernst, S. E., Fan, L., Hornick, D. B., Karp, P. H., Khan, U., Lymp, J. F., Ostmann, A. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073905 · Cited by 59 · see citing works
Detection of CFTR function and modulation in primary human nasal cell spheroids
Brewington, J. J., Filbrandt, E. T., LaRosa, F. J., Ostmann, A. J., Strecker, L. M., Szczesniak, R. D., & Clancy, J. P. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.06.010 · Cited by 57 · see citing works
Ommen, D. D. Z.-V., de Poel, E., Kruisselbrink, E., Oppelaar, H., Vonk, A. M., Janssens, H. M., van der Ent, C. K., Hagemeijer, M. C., & Beekman, J. M. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.02.007 · Cited by 55 · see citing works
Castillon, N., Hinnrasky, J., Zahm, J., Kaplan, H., Bonnet, N., Corlieu, P., Klossek, J., Taouil, K., Avril‐Delplanque, A., Péault, B., et al. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000022221.88025.43 · Cited by 52 · see citing works
de Courcey, F., Zholos, A. V., Atherton, H. C., Williams, M. T. S., Canning, P., Danahay, H. L., Elborn, J. S., & Ennis, M. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00384.2011 · Cited by 49 · see citing works
The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis
Guevara, M. T., & McColley, S. A. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1372419 · Cited by 46 · see citing works
Nasospheroids permit measurements of CFTR-dependent fluid transport
Guimbellot, J. S., Leach, J. M., Chaudhry, I. G., Quinney, N. L., Boyles, S. E., Chua, M., Aban, I., Jaspers, I., & Gentzsch, M. (2017) · JCI Insight · doi:10.1172/jci.insight.95734 · Cited by 45 · see citing works
Lopes‐Pacheco, M., Boinot, C., Sabirzhanova, I. B., Rapino, D., & Cebotaru, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000475578 · Cited by 42 · see citing works
Taylor, C. J., Hardcastle, J., & Southern, K. W. (2009) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2009.05.002 · Cited by 38 · see citing works
Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis
Cohen‐Cymberknoh, M., Yaakov, Y., Shoseyov, D., Shteyer, E., Shachar, E., Rivlin, J., Bentur, L., Picard, E., Aviram, M., Israeli, E., et al. (2012) · Pediatric Pulmonology · doi:10.1002/ppul.22586 · Cited by 36 · see citing works
R560S: A class II CFTR mutation that is not rescued by current modulators
Awatade, N. T., Ramalho, S. S., Silva, I. A. L., Felício, V., Botelho, H. M., de Poel, E., Vonk, A. M., Beekman, J. M., Farinha, C. M., & Amaral, M. D. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.07.001 · Cited by 36 · see citing works
Self-citationCultured human nasal epithelial multicellular spheroids: polar cyst-like model tissues
Bridges, M. A., Walker, D. C., Harris, R. A., Wilson, B. R., & Davidson, A. G. F. (1991) · Biochemistry and Cell Biology · doi:10.1139/o91-016 · Cited by 36 · see citing works
Ion transport in epithelial spheroids derived from human airway cells
Pedersen, P. S., Frederiksen, O., Holstein‐Rathlou, N., Larsen, P. L., & Qvortrup, K. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.1.l75 · Cited by 34 · see citing works
Deslée, G., Dury, S., Perotin, J., Alam, D. A., Vitry, F., Boxio, R., Gangloff, S. C., Guenounou, M., Lebargy, F., & Belaaouaj, A. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-86 · Cited by 30 · see citing works
Personalised CFTR pharmacotherapeutic response testing and therapy of cystic fibrosis
McCarthy, C., Brewington, J. J., Harkness, B., Clancy, J. P., & Trapnell, B. C. (2018) · European Respiratory Journal · doi:10.1183/13993003.02457-2017 · Cited by 29 · see citing works
Czerwinski, M. J., & Spence, J. R. (2017) · Cell stem cell · doi:10.1016/j.stem.2016.12.010 · Cited by 27 · see citing works
Brewington, J. J., Filbrandt, E. T., LaRosa, F. J., Moncivaiz, J. D., Ostmann, A. J., Strecker, L. M., & Clancy, J. P. (2018) · Journal of Visualized Experiments · doi:10.3791/57492 · Cited by 27 · see citing works
Induced pluripotent stem cells for treating cystic fibrosis: State of the science
Pollard, B. S., & Pollard, H. B. (2018) · Pediatric Pulmonology · doi:10.1002/ppul.24118 · Cited by 24 · see citing works
Measurement of Ion Transport Function in Rectal Biopsies
Hug, M. J., Derichs, N., Bronsveld, I., & Clancy, J. P. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-117-8_7 · Cited by 24 · see citing works
Ion Channels of the Gastrointestinal Epithelial Cells
Rajendran, V. M., Schulzke, J., & Seidler, U. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00058-x · Cited by 18 · see citing works
Dye, B. R., Kasputis, T., Spence, J., & Shea, L. (2017) · MRS Communications · doi:10.1557/mrc.2017.61 · Cited by 4 · see citing works
Sutanto, E. N., Scaffidi, A. K., Garratt, L. W., Looi, K., Foo, C. J., Tessari, M. A., Janssen, R. A. J., Fischer, D. F., Stick, S. M., Kicic, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191618 · Cited by 4 · see citing works
Self-citation
Flagged first, then by citations
1 of the 77 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lopes‐Pacheco, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01662 · Cited by 571 · see citing works
Baldassi, D., Gabold, B., & Merkel, O. M. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202000111 · Cited by 163 · see citing works
A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion
Sharma, J., Du, M., Wong, E., Mutyam, V., Li, Y., Chen, J., Wangen, J. R., Thrasher, K., Fu, L., Peng, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24575-x · Cited by 129 · see citing works
Animal and Cell Culture Models for Cystic Fibrosis
McCarron, A., Parsons, D., & Donnelley, M. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.10.017 · Cited by 84 · see citing works
Long-term differentiating primary human airway epithelial cell cultures: how far are we?
Bukowy‐Bieryłło, Z. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00740-z · Cited by 82 · see citing works
Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing
Maule, G., Casini, A., Montagna, C., Ramalho, A. S., De Boeck, K., Debyser, Z., Carlon, M. S., Petris, G., & Cereseto, A. (2019) · Nature Communications · doi:10.1038/s41467-019-11454-9 · Cited by 86 · see citing works
Rijsbergen, L. C., van Dijk, L. L. A., Engel, M. F. M., de Vries, R. D., & de Swart, R. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683002 · Cited by 67 · see citing works
Recent advances in human respiratory epithelium models for drug discovery
Yaqub, N., Wayne, G. J., Birchall, M., & Song, W. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107832 · Cited by 58 · see citing works
Assays of CFTR Function In Vitro, Ex Vivo and In Vivo
Ramalho, A. S., Boon, M., Proesmans, M., Vermeulen, F. L., Carlon, M. S., & Boeck, K. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031437 · Cited by 47 · see citing works
Steric Inhibition of 5′ UTR Regulatory Elements Results in Upregulation of Human CFTR
Sasaki, S., Sun, R., Bui, H., Crosby, J. R., Monia, B. P., & Guo, S. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.06.016 · Cited by 45 · see citing works
In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease
Heinen, N., Klöhn, M., Steinmann, E., & Pfaender, S. (2021) · Viruses · doi:10.3390/v13050792 · Cited by 41 · see citing works
Sung, T., Wang, T., Liu, Q., Ling, Q., Kumar, S. S., Renuka, R. R., Hsu, S.-T., Umezawa, A., & Higuchi, A. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02601e · Cited by 44 · see citing works
Alwani, S., Wasan, E. K., & Badea, I. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00128 · Cited by 43 · see citing works
Molecular Diagnosis and Genetic Counseling of Cystic Fibrosis and Related Disorders: New Challenges
Bienvenu, T., Lopez, M., & Girodon, E. (2020) · Genes · doi:10.3390/genes11060619 · Cited by 42 · see citing works
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
Jonker, A. H., Tãtaru, E.-A., Graeßner, H., Dimmock, D., Jaffé, A., Baynam, G. S., Davies, J. O. J., Mitkus, S., Iliach, O., Horgan, R., et al. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01059-3 · Cited by 41 · see citing works
Human lung cell models to study aerosol delivery – considerations for model design and development
Rothen‐Rutishauser, B., Gibb, M., He, R., Petri‐Fink, A., & Sayes, C. M. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106337 · Cited by 39 · see citing works
Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies
Allan, K. M., Farrow, N., Donnelley, M., Jaffé, A., & Waters, S. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.639475 · Cited by 39 · see citing works
Self-citationEfficient RNP-directed Human Gene Targeting Reveals SPDEF Is Required for IL-13–induced Mucostasis
Koh, K. D., Siddiqui, S., Cheng, D., Bonser, L. R., Sun, D. I., Zlock, L. T., Finkbeiner, W. E., Woodruff, P. G., & Erle, D. J. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0266oc · Cited by 38 · see citing works
The genetics and genomics of cystic fibrosis
Sharma, N., & Cutting, G. R. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.11.003 · Cited by 38 · see citing works
Lee, R. E., Lewis, C. A., He, L., Bulik‐Sullivan, E. C., Gallant, S. C., Mascenik, T., Dang, H., Cholon, D. M., Gentzsch, M., Morton, L. C., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154571 · Cited by 36 · see citing works
Tan, C. L., Chan, Y., Candasamy, M., Chellian, J., Madheswaran, T., Sakthivel, L. P., Patel, V. K., Chakraborty, A., MacLoughlin, R. J., Kumar, D., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174821 · Cited by 37 · see citing works
Singh, A. K., Fan, Y., Balut, C., Alani, S., Manelli, A. M., Swensen, A. M., Jia, Y., Neelands, T. R., Vortherms, T. A., Liu, B., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.261800 · Cited by 32 · see citing works
The era of CFTR modulators: improvements made and remaining challenges
Ocaña, S. C., Laselva, O., Avolio, J., & Nenna, R. (2020) · Breathe · doi:10.1183/20734735.0016-2020 · Cited by 34 · see citing works
Boecking, C. A., Walentek, P., Zlock, L. T., Sun, D. I., Wolters, P. J., Ishikawa, H., Jin, B., Haggie, P. M., Marshall, W. F., Verkman, A. S., et al. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00536.2020 · Cited by 32 · see citing works
Stelzer‐Braid, S., Walker, G. J., Aggarwal, A., Isaacs, S. R., Yeang, M., Naing, Z., Stella, A. O., Turville, S. G., & Rawlinson, W. D. (2020) · Pathology · doi:10.1016/j.pathol.2020.09.012 · Cited by 26 · see citing works
An organoid model to assay the role of CFTR in the human epididymis epithelium
Leir, S., Yin, S., Kerschner, J. L., Xia, S., Ahmadi, S., Bear, C. E., & Harris, A. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03208-7 · Cited by 26 · see citing works
Balázs, A., Millar-Büchner, P., Mülleder, M., Farztdinov, V. M., Szyrwiel, Ł., Addante, A., Kuppe, A., Rubil, T., Drescher, M., Seidel, K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.822437 · Cited by 26 · see citing works
Current landscape of cystic fibrosis gene therapy
Plasschaert, L. W., MacDonald, K. D., & Moffit, J. S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1476331 · Cited by 27 · see citing works
Mechanism-Based Personalized Medicine for Cystic Fibrosis by Suppressing Pseudo Exon Inclusion
Shibata, S., Ajiro, M., & Hagiwara, M. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.08.013 · Cited by 23 · see citing works
Pintacuda, G., Martín, J. M., & Eggan, K. C. (2021) · Molecular Autism · doi:10.1186/s13229-021-00417-x · Cited by 26 · see citing works
Laselva, O., Allegretta, C., Gioia, S. D., Avolio, C., & Conese, M. (2021) · Cells · doi:10.3390/cells10082132 · Cited by 23 · see citing works
Mucus-producing 3D cell culture models
Macedo, M. H., Baião, A., Pinto, S. F. T., Barros, A. S., Almeida, H., Almeida, A., das Neves, J., & Sarmento, B. F. C. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113993 · Cited by 18 · see citing works
Mazio, C., Scognamiglio, L. S., Passariello, R., Panzetta, V., Casale, C., Urciuolo, F., Galietta, L. J. V., Imparato, G., & Netti, P. A. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01460 · Cited by 17 · see citing works
Boeck, K. D., Lee, T., Amaral, M. D., Dřevı́nek, P., Elborn, J. S., Fajac, I., Kerem, E., & Davies, J. C. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.05.012 · Cited by 18 · see citing works
Laucirica, D. R., Garratt, L. W., & Kicic, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00595 · Cited by 18 · see citing works
Self-citationCurrent and future diagnosis of cystic fibrosis: Performance and limitations
Bienvenu, T., & Nguyen‐Khoa, T. (2020) · Archives de Pédiatrie · doi:10.1016/s0929-693x(20)30046-4 · Cited by 15 · see citing works
Lee, M., Lee, S., Jung, C., Son, Y. S., Ryu, J.-W., Jung, K. B., Ahn, J., Oh, J., Lee, H., Lim, J. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24746-w · Cited by 14 · see citing works
Wong, S. L., Awatade, N. T., Astore, M. A., Allan, K. M., Carnell, M. J., Šlapetová, I., Chen, P., Capraro, A., Fawcett, L. K., Whan, R. M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103710 · Cited by 13 · see citing works
Self-citationKulhánková, K., Cheng, A. X., Traore, S., Auger, M., Pelletier, M., Hervault, M., Wells, K. D., Green, J. A., Byrne, A. K., Nelson, B., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae819 · Cited by 13 · see citing works
Development and Characterization of a 96‐Well Exposure System for Safety Assessment of Nanomaterials
Kohl, Y., Müller, M., Fink, M., Mamier, M., Fürtauer, S., Drexel, R., Herrmann, C. H., Dähnhardt‐Pfeiffer, S., Hornberger, R., Arz, M. I., et al. (2023) · Small · doi:10.1002/smll.202207207 · Cited by 10 · see citing works
Mazio, C., Scognamiglio, L. S., Cegli, R. D., Galietta, L. J. V., di Bernardo, D., Casale, C., Urciuolo, F., Imparato, G., & Netti, P. A. (2020) · Cells · doi:10.3390/cells9061371 · Cited by 12 · see citing works
Molecular and Functional Characteristics of Airway Epithelium under Chronic Hypoxia
Wong, S. L., Kardia, E., Vijayan, A., Umashankar, B., Pandžić, E., Zhong, L., Jaffé, A., & Waters, S. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076475 · Cited by 10 · see citing works
Self-citationFawcett, L. K., Turgutoğlu, N., Allan, K. M., Belessis, Y., Widger, J., Jaffé, A., & Waters, S. A. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050864 · Cited by 11 · see citing works
Self-citationThree-Dimensional Airway Spheroids and Organoids for Cystic Fibrosis Research
Laselva, O., & Conese, M. (2021) · Journal of Respiration · doi:10.3390/jor1040022 · Cited by 11 · see citing works
Fawcett, L. K., Wakefield, C. E., Sivam, S., Middleton, P. G., Wark, P. A. B., Widger, J., Jaffé, A., & Waters, S. A. (2020) · ERJ Open Research · doi:10.1183/23120541.00448-2020 · Cited by 11 · see citing works
Self-citationValidation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis
Calucho, M., Gärtner, S., Barranco, P., Fernández‐Álvarez, P., Pérez, R. G., & Tizzano, E. F. (2021) · Scientific Reports · doi:10.1038/s41598-021-94798-x · Cited by 11 · see citing works
Antimicrobials: An update on new strategies to diversify treatment for bacterial infections
Hibbert, T. M., Krpetić, Ž., Latimer, J., Leighton, H. J., McHugh, R. E., Pottenger, S., Wragg, C., & James, C. E. (2024) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2023.12.002 · Cited by 10 · see citing works
CFTR Modulator Therapy for Rare CFTR Mutants
Mergiotti, M., Murabito, A., Prono, G., & Ghigo, A. (2022) · Journal of Respiration · doi:10.3390/jor2020005 · Cited by 10 · see citing works
Carbone, A., Vitullo, P., Gioia, S. D., & Conese, M. (2023) · Genes · doi:10.3390/genes14101966 · Cited by 10 · see citing works
Human Induced Lung Organoids: A Promising Tool for Cystic Fibrosis Drug Screening
Demchenko, A. G., Balyasin, M. V., Nazarova, A. G., Grigorieva, O., Panchuk, I., Kondrateva, E. V., Tabakov, V. Y., Shchagina, O., Amelina, E., & Smirnikhina, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020437 · Cited by 9 · see citing works
Allan, K. M., Astore, M. A., Fawcett, L. K., Wong, S. L., Chen, P., Griffith, R., Jaffé, A., Serdar Kuyucak, B., & Waters, S. A. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.1062766 · Cited by 8 · see citing works
Self-citationWoodall, M. N. J., Tarran, R., Lee, R. E., Anfishi, H., Prins, S., Counsell, J. R., Vergani, P., Hart, S. L., & Baines, D. L. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.08.006 · Cited by 9 · see citing works
Arruda-Silva, F., Bellavite, P., & Marzotto, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-81843-y · Cited by 9 · see citing works
Montefusco-Pereira, C. V., Carvalho‐Wodarz, C. D. S., Seeger, J., Kloft, C., Michelet, R., & Lehr, C. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.016 · Cited by 7 · see citing works
Mohtasham, N., Mohajertehran, F., & Abbaszadeh, H. (2022) · Health Science Reports · doi:10.1002/hsr2.580 · Cited by 6 · see citing works
Tuning parameter calibration for personalized prediction in medicine
Huang, S., Düren, Y., Hellton, K. H., & Lederer, J. (2021) · Electronic Journal of Statistics · doi:10.1214/21-ejs1884 · Cited by 6 · see citing works
Barton, T. E., Frost, F., Fothergill, J. L., & Neill, D. R. (2022) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001643 · Cited by 5 · see citing works
Tuning parameter calibration for prediction in personalized medicinePreprint
Huang, S., Düren, Y., Hellton, K. H., & Lederer, J. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1909.10635 · Cited by 6 · see citing works
Ludovico, A., & Baroni, D. (2025) · Life · doi:10.3390/life15081315 · Cited by 6 · see citing works
Allan, K. M., Astore, M. A., Kardia, E., Wong, S. L., Fawcett, L. K., Bell, J. L., Visser, S. K., Chen, P., Griffith, R., Jaffé, A., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1148501 · Cited by 4 · see citing works
Self-citationAiyer, A., Das, T., Whiteley, G. S., Glasbey, T. O., Kriel, F. H., Farrell, J., & Manos, J. (2022) · Biomedicines · doi:10.3390/biomedicines10112886 · Cited by 5 · see citing works
Systems Pharmacology: Enabling Multidimensional Therapeutics
Maudsley, S. R., Leysen, H., van Gastel, J., & Martin, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00017-7 · Cited by 4 · see citing works
Dastidar, D. G., Ghosh, D., Ghosh, S., & Chakrabarti, G. (2021) · Springer eBooks · doi:10.1007/978-981-33-6827-9_38 · Cited by 4 · see citing works
Mazio, C., Scognamiglio, L. S., Casale, C., Panzetta, V., Urciuolo, F., Galietta, L. J. V., Imparato, G., & Netti, P. A. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122546 · Cited by 4 · see citing works
CFTR Modulator Response in Nasal Organoids Derived from People with Cystic Fibrosis
Cicero, S. L., Castelli, G., Ceci, A., Cerio, A. M., Blaconà, G., Virgulti, M., Allushi, S., Sette, G., Spadaro, F., Amato, F., et al. (2025) · Cells · doi:10.3390/cells14231914 · Cited by 3 · see citing works
Latorre, R. V., Mortali, C., Lotti, V., Kleinfelder, K., Melotti, P., & Sorio, C. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178612 · Cited by 2 · see citing works
Lopez, J. A. M. (2022) · Open Access Journal of Biomedical Science · doi:10.38125/oajbs.000493 · Cited by 2 · see citing works
Exploring Therapeutic Strategies for Pediatric Cystic Fibrosis: An In-Depth Comparative Review
Lakhani, A., Clementina, R., Siddiqua, Z., Shroff, S., Bhavanam, S., Pandya, M. H., Bagadia, B., Khan, U., Machingal, M. M. K., Kimmatkar, A., et al. (2024) · Cureus · doi:10.7759/cureus.71913 · Cited by 1 · see citing works
Gambari, R., & Finotti, A. (2025) · Molecules · doi:10.3390/molecules30214155 · Cited by 1 · see citing works
Hossain, M. K., & Kim, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2025.1733234 · Cited by 1 · see citing works
Hynds, R. E., Ryan, A. L., & González, M. V. (2026) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2026.04.010 · Cited by 1 · see citing works
Predictive capacity of paediatric nasal epithelial cells in sequential CFTR modulator therapy
Fawcett, L. K., Chew, Z. A., Schneider‐Futschik, E. K., Allan, K. M., Patel, H. R., Jaffé, A., & Waters, S. A. (2025) · Thorax · doi:10.1136/thorax-2025-223153 · Cited by 2 · see citing works
Self-citationMunir, M., Wiyana, J., Werder, R. B., Butcher, N. J., Burow, R., McCarron, A., Yu, Q., Waters, S. A., & Kaminskas, L. M. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2684641 · Cited by 1 · see citing works
Self-citationCallebaut, I., Mense, M., & Farinha, C. M. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.12.013 · Cited by 1 · see citing works
Sekowski, V., Leung, W., Ferrara, G., & Lam, G. Y. (2023) · Pharmacogenomics Research and Personalized Medicine · doi:10.21037/prpm-22-12
Infrared biomarkers of impaired cystic fibrosis transmembrane regulator protein biogenesis
Bellisola, G., Caldrer, S., Guidi, M. C., & Cinque, G. (2019) · Journal of Biophotonics · doi:10.1002/jbio.201900174
Bonciu, A. F., Wagner, A., Mărăscu, V., Moldovan, A., Dinu, C. Z., & Dinca, V. C. (2020) · Applied Sciences · doi:10.3390/app10186299
Robust W1282X-CFTR rescue by a small molecule GSPT1 degraderPreprint
Lee, R. E., Lewis, C. A., He, L., Gallant, S. C., Mascenik, T., Dang, H., Morton, L. C., Minges, J. T., Theile, J. W., Castle, N. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.28.462149
Wong, S. L., Awatade, N. T., Astore, M. A., Allan, K. M., Carnell, M. J., Šlapetová, I., Chen, P., Capraro, A., Fawcett, L. K., Whan, R. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.12.472297
Self-citationLee, M., Lee, S., Jung, C., Ryu, J., Son, Y. S., Jung, K. B., Ahn, J., Oh, J., Kim, J., Jang, I., et al. (2020) · doi:10.21203/rs.3.rs-60397/v1
Research Trends in Lung Organoids: Bibliometric Analysis and VisualizationPreprint
Peng, X., Li, F., Ma, Q., Tan, S.-Y., Jiang, H., Ye, X., Dong, J., You, F., Ren, Y., & Zheng, C. (2023) · Research Square · doi:10.21203/rs.3.rs-2549798/v1
Tokarchuk, I., Mushii, O., Dreus, A., Koziaruk, A. A., Shapochka, D. O., Ryzhak, O. A., Venhryk, S. O., Golovko, I. S., Ryabuhin, S. V., Hanopolskyi, A. I., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.26.529716
Mia, M., Oany, A. R., Bhowmik, M., Pervin, T., & Duza, S. S. (2023) · Research Square · doi:10.21203/rs.3.rs-3031398/v1
Bronchial epithelial cells in cystic fibrosis: What happens in SARS-CoV-2 infection?
Lagni, A., Diani, E., Gibellini, D., & Lotti, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18703-2.00004-9
Diagnóstico e tratamento atuais da fibrose cística: uma revisão de literatura
Cardoso, E. G., Dias, R. O., Ferreira, N. M. C., Cardoso, J. L. G., Oliveira, C. D. M., Carvalho, L. N., Oliveira, L. R., & Rocha, M. B. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n4-216 · Cited by 1 · see citing works
Bioactive‐Based Nanocarriers for the Treatment of Lung Disorders
Ganguly, S. C., Giri, S., & Kundu, M. (2025) · Wiley eBooks · doi:10.1002/9781394287345.ch18
Fawcett, L. K., Chew, Z. A., Schneider‐Futschik, E. K., Allan, K. M., Patel, H. R., Jaffé, A., & Waters, S. A. (2025) · medRxiv · doi:10.1101/2025.07.09.25331152
Self-citationLin, Y., Lin, H., Yu, D., & Welsher, K. (2026) · Viruses · doi:10.3390/v18050521
Somatic mutations in endometrial epithelium: biological insights and emerging in vitro models
Subramaniam, S., Gargett, C. E., Fitzgerald, H. C., Montgomery, G. W., & McKinnon, B. D. (2026) · Molecular Human Reproduction · doi:10.1093/molehr/gaag027
Ludovico, A., Battistini, M., & Baroni, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114868
Targeted Therapy for Restoring CFTR Activity: From Experimental to Clinical Features
Allushi, S., Virgulti, M., Blaconà, G., Ferraguti, G., Eramo, A., & Lucarelli, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156919
Alotaibi, M. S., Nahari, F. M., Alsaeedi, F. A. A., Hakami, S. A., Awwas, M. Y. A., Azzeem, R. A., Al-khalaf, A. S., Basha, M. M., Aljasim, H. A., Alharbi, T. M. H., et al. (2025) · International Journal of Computational and Experimental Science and Engineering · doi:10.22399/ijcesen.5494
- Authors
- Awatade, N. T., Wong, S. L., Hewson, C. K., Fawcett, L. K., Kicic, A., Jaffe, A., & Waters, S. A.
- Affiliations
- UNSW Sydney (AU)
- The Kids Research Institute Australia (AU)
- Corresponding author
- Waters, Shafagh A.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-12-07
- Volume
- 9
- Pages
- 1429-1429
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC6293199
- OpenAlex
- W2903274455
- Cited by
- 92
- References
- 77
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 9 · 2023: 12 · 2022: 12 · 2021: 20 · 2020: 16 · 2019: 7
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eSpace (Curtin University) (submittedVersion, cc-by)
- Funders
- University of New South Wales
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- cystic fibrosis, CFTR mutations, organoids, patient-derived organoids, personalized medicine, intestinal organoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review